Bionomics Limited Short Interest Up 278.6 percent in January
BNOXDelisted Stock | USD 4.88 0.07 1.41% |
Slightly above 66% of BNOX Old's investor base is looking to short. The analysis of current outlook of investing in BNOX Old suggests that many traders are alarmed regarding BNOX Old's prospects. BNOX Old's investing sentiment can be driven by a variety of factors including economic data, BNOX Old's earnings reports, geopolitical events, and overall market trends.
BNOX |
Bionomics Limited was the target of a significant growth in short interest in January. As of January 31st, there was short interest totalling 5,300 shares, a growth of 278.6 percent from the January 15th total of 1,400 shares. Based on an average daily volume of 10,100 shares, the short-interest ratio is currently
Read at thelincolnianonline.com
![]() |
BNOX Old Fundamental Analysis
We analyze BNOX Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BNOX Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BNOX Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
BNOX Old is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
BNOX Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BNOX Old stock to make a market-neutral strategy. Peer analysis of BNOX Old could also be used in its relative valuation, which is a method of valuing BNOX Old by comparing valuation metrics with similar companies.
Peers
BNOX Old Related Equities
ACRV | Acrivon Therapeutics, | 4.55 | ||||
PMVP | Pmv Pharmaceuticals | 3.57 | ||||
SPRC | Scisparc | 3.23 | ||||
ADAG | Adagene | 1.72 | ||||
ANEB | Anebulo Pharmaceuticals | 0.99 | ||||
RZLT | Rezolute | 0.28 | ||||
ANTX | AN2 Therapeutics | 1.63 | ||||
ACUT | Accustem Sciences | 15.00 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in BNOX Stock
If you are still planning to invest in BNOX Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BNOX Old's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
CEOs Directory Screen CEOs from public companies around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |